AKT1 and lung cancer: The ratio of total AKT to pAKTSer473 was approximately 1:1 in both control-treated lung cancer cell lines (Figure 5B,E), but in siRNA treated cells we found this ratio shifted towards 1:2 and 1:3, respectively.